• DOI:10.1097/01.ftd.0000177223.19294.5c
Corpus ID: 12979224

Randomized, Double-Blind, Placebo-Controlled Study About the Effects of Cannabidiol (CBD) on the Pharmacokinetics of Δ9-Tetrahydrocannabinol (THC) After Oral Application of THC Verses Standardized Cannabis Extract

@article{Nadulski2005RandomizedDP,
  title={Randomized, Double-Blind, Placebo-Controlled Study About the Effects of Cannabidiol (CBD) on the Pharmacokinetics of Δ9-Tetrahydrocannabinol (THC) After Oral Application of THC Verses Standardized Cannabis Extract},
  author={T. Nadulski and F. Pragst and G. Weinberg and P. Roser and M. Schnelle and E. Fronk and A. Stadelmann},
  journal={Therapeutic Drug Monitoring},
  year={2005},
  volume={27},
  pages={799-810}
}

• T. Nadulski, F. Pragst, +4 authors A. Stadelmann
• Published 2005
• Chemistry, Medicine
• Therapeutic Drug Monitoring

Cannabidiol (CBD) is known to modify the effects of Delta-tetrahydrocannabinol (THC) by decreasing anxiety and antagonizing other THC-effects. [...] Key Method In context of the use of cannabis-based medicine extracts for therapeutic purposes, a study was performed in a double-blind and placebo-controlled cross-over design in which each of 24 volunteers (12 male and 12 female, age 18-45 years) obtained soft-gelatin capsules with 10 mg THC (THC-set), cannabis extract containing 10 mg THC +5.4 mg CBD (CAN-set) or…Expand

View on Wolters Kluwer

thblack.com

Save to Library

Create Alert

Cite

Launch Research Feed